4Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J, 2005, 26( 1 ) : 153-161. 被引量：1
5Miller MR, lqankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J, 2005, 26(2): 319-338. 被引量：1
6Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J, 2005, 26 ( 3 ) : 511- 522. 被引量：1
7MacIntyre N, Crapo RO, Viegi G, et al, Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J, 2005, 26(4): 720-735. 被引量：1
8Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005, 26(5) : 948-968. 被引量：1
9Reid DW, Soltani A, Johns DP, et al. Bwnchodilator reversibility in australian adults with chronic obstructive pulmonary disease. Intern Med J,2003,33:572-577. 被引量：1
10Paul O' Byrne. Global Strategy for Asthma Management and Prevention [ DB/OL]. Hamilton.. GINA Executive Committee, 2006 [ 2007-7-11 ] http ://www. ginasthma, com/GuidelineItem. asp.9 intId =60. 被引量：1
